Regulations.gov document: Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry; Availability

retained text

Query: data center
Agency: FDA
Type: Notice
Docket: FDA-2026-D-8561
Comment end: 2026-11-19T04:59:59Z

document fetched 2026-08-21 06:30 · canonical https://regulations.gov/document/FDA-2026-D-8561-0001